Innovating Works
EU4H-2024-PJ-03-4
Call for proposals on Personalised Cancer Medicine - (CR-g-24-99)
Expected Impact:The action will benefit cancer patients accessing personalised cancer medicine services, which is expected to reduce the burden of cancer in the Member States.
Sólo fondo perdido 0 €
European
This call is closed This line is already closed so you can't apply. It closed last day 22-01-2025.
Esta ayuda tiene otras 31 convocatoria(s) que puedes consultar.
Hace 8 mes(es) del cierre de la convocatoria y aún no tenemos información sobre los proyectos financiados, puede que esta información se publique pronto.
Presentation: Consortium Consortium: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Minimum number of participants.
This aid finances Proyectos: project objective:

Expected Impact:The action will benefit cancer patients accessing personalised cancer medicine services, which is expected to reduce the burden of cancer in the Member States.

The expected results will include initiatives to complement the Member States’ efforts in the design, planning and implementation of best practices, such as support for the development of public health guidelines (e.g., personalised cancer medicine, genomic testing/screening and metastatic cancer management) guidelines and, support for the preparation and roll out of new policy approaches; participation in the pilot testing of innovative practices; development of capacity building actions such as training and twinning, health communication or health literacy.

The actions that will complement the Joint Action on Personalized Cancer Medicine are expected to bring short-term improvements in implementing personalised cancer medicine and sharing best practice among Member States and countries associated to the EU4Health Programme. In the mid- to long- term, this is expected to improve innovation and patient management in the cancer pathway, including metastatic cancer, by improving knowle... see more

Expected Impact:The action will benefit cancer patients accessing personalised cancer medicine services, which is expected to reduce the burden of cancer in the Member States.

The expected results will include initiatives to complement the Member States’ efforts in the design, planning and implementation of best practices, such as support for the development of public health guidelines (e.g., personalised cancer medicine, genomic testing/screening and metastatic cancer management) guidelines and, support for the preparation and roll out of new policy approaches; participation in the pilot testing of innovative practices; development of capacity building actions such as training and twinning, health communication or health literacy.

The actions that will complement the Joint Action on Personalized Cancer Medicine are expected to bring short-term improvements in implementing personalised cancer medicine and sharing best practice among Member States and countries associated to the EU4Health Programme. In the mid- to long- term, this is expected to improve innovation and patient management in the cancer pathway, including metastatic cancer, by improving knowledge and skills in implementing personalised medicine in oncology.

Objective:The aim of the action is to complement the implementation of the ‘Joint Action on Personalized Cancer Medicine’ led by the Member States, thus helping to reduce the burden of cancer both at a personal and societal level, namely by supporting the Europe’s Beating Cancer Plan and policy initiatives on personalised medicine. It may also support other Union initiatives that aim at improving public health, such as the ‘1+ Million Genomes’ Initiative and the Initiative to Understand Cancer (UNCAN.eu) in so far as it shares the objectives of promoting personalised treatments and support ground-breaking research needed to advance the understanding of cancer mechanisms in order to improve the cancer care pathway.

This action should cover the ambition of the sixth flagship of the Europe’s Beating Cancer Plan, the ‘Cancer diagnostic and treatment for all’ initiative. It will build on the results of the

EU4Health Programme funded projects, such as the Personalised Cancer Medicine for all EU citizens (‘PCM4EU’), the EU Cancer and Public Health Genomics platform project (‘CAN.HEAL’), as well as the project for improved diagnostics and survival for all children with Acute Myeloid and the Leukaemia treated within the NOPHO-DB- SHIP consortium; a cross-European collaboration (‘CHIP-AML22’). The action will also make use of the guidelines, protocols and best practices, developed under other European Commission funded initiatives and projects such as the 1+ Million Genomes Initiative, a European-wide foundation to accelerate Data-driven Cancer Research (EOSC4Cancer), and Partnership on Transforming Health and Care Systems (THCS) as well as Innovative Health Initiative (IHI)funded projects could also be considered.

Scope:Activities will contribute to the Joint Action on Personalized Cancer Medicine’, and include:

a) the implementation of targeted projects involving civil society organisations and industry complementing the Member States’ efforts in the design, planning and implementation of best practices (e.g., on metastatic cancer);

b) the production of public health guidelines concerning personalised cancer medicine, genomic testing/screening and metastatic cancer management;

c) patients and caregivers consultations, and other actions that can benefit citizens directly;

d) preparation and roll out of innovative practices;

e) support capacity building actions such as training and twinning, health communication or health literacy.

Activities should also include an equity dimension and aim at reducing health inequalities.

see less

Temáticas Obligatorias del proyecto: Temática principal:

Consortium characteristics

Scope European : The aid is European, you can apply to this line any company that is part of the European Community.
Tipo y tamaño de organizaciones: The necessary consortium design for the processing of this aid needs:

characteristics of the Proyecto

Requisitos de diseño por participante: Duración:
Requisitos técnicos: Expected Impact:The action will benefit cancer patients accessing personalised cancer medicine services, which is expected to reduce the burden of cancer in the Member States. Expected Impact:The action will benefit cancer patients accessing personalised cancer medicine services, which is expected to reduce the burden of cancer in the Member States.
Financial Chapters: The chapters of financing expenses for this line are:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Madurez tecnológica: The processing of this aid requires a minimum technological level in the project of TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Characteristics of financing

Intensidad de la ayuda: Sólo fondo perdido + info
Lost Fund:
Conditions Conditions1. Admissibility conditions: described in section 5 of the Call document
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in section 6 of the Call document
3. Other eligibility conditions: described in section 6 of the Call document
4. Financial and operational capacity and exclusion: described in section 7 of the Call document
Submission and evaluation processes: described section 8 of the call document and the Online ManualAward criteria, scoring and thresholds: described in section 9 of the call documentIndicative timeline for evaluation and grant agreement: described in section 4 of the Call document6. Legal and financial set-up of the grants: described in section 10 of the Call document
Call document
Standard application form ([ToA])
Detailed budget table ([ToA])
EU4Health Programme General MGA v1.1
EU4Health Work Programme 2024
EU4Health Regulation 2021/522
EU Financial Regulation 2018/1046
Conditions Conditions1. Admissibility conditions: described in section 5 of the Call document
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in section 6 of the Call document
3. Other eligibility conditions: described in section 6 of the Call document
4. Financial and operational capacity and exclusion: described in section 7 of the Call document
Submission and evaluation processes: described section 8 of the call document and the Online ManualAward criteria, scoring and thresholds: described in section 9 of the call documentIndicative timeline for evaluation and grant agreement: described in section 4 of the Call document6. Legal and financial set-up of the grants: described in section 10 of the Call document
Call document
Standard application form ([ToA])
Detailed budget table ([ToA])
EU4Health Programme General MGA v1.1
EU4Health Work Programme 2024
EU4Health Regulation 2021/522
EU Financial Regulation 2018/1046
Guarantees:
does not require guarantees
No existen condiciones financieras para el beneficiario.

Additional information about the call

incentive effect: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
non -competitive competitive Very competitive
We do not know the total budget of the line
minimis: Esta línea de financiación NO considera una “ayuda de minimis”. You can consult the regulations here.

other advantages

SME seal: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
EU4H-2024-PJ-04-01 Call for proposals for EU-USA cooperation on lung cancer
en consorcio: Expected Impact:The cooperation on lung cancer is expected to generate new data and findings on lung cancer screening and mortality, and to...
Próximamente
EU4H-2024-PJ-03-2-c Call for proposals on health promotion and prevention of noncommunicable and communicable diseases, including vaccine-preventable and other cancers caused by infections, and on smoke- and aer
en consorcio: Expected Impact:Sub-topic (c): The expected results include: a) identification and piloting of best and promising practices through popu...
Cerrada does 8 months | next call scheduled for the month of
EU4H-2024-PJ-03-1 Call for proposals to support a comprehensive, prevention-oriented approach to mental health in the Union - (DP-g-24-25)
en consorcio: Expected Impact:The expected results of this action are an improved and accelerated move towards the development and implementation of a com...
Cerrada does 8 months | next call scheduled for the month of
EU4H-2024-PJ-03-3 Call for Proposals on radiation safety and quality of computed tomography imaging of children and young adults - (CR-g-24-42)
en consorcio: Expected Impact:As an expected outcome of the activities and in line with the SAMIRA objective to ensure that applications of ionising radia...
Cerrada does 8 months | next call scheduled for the month of
EU4H-2024-PJ-03-4 Call for proposals on Personalised Cancer Medicine - (CR-g-24-99)
en consorcio: Expected Impact:The action will benefit cancer patients accessing personalised cancer medicine services, which is expected to reduce the bur...
Cerrada does 8 months | next call scheduled for the month of
EU4H-2024-PJ-03-2-a Call for proposals on health promotion and prevention of noncommunicable and communicable diseases, including vaccine-preventable and other cancers caused by infections, and on smoke- and aer
en consorcio: Expected Impact:Sub-topic (a): The expected results include: a) identification and piloting of best and promising practices through popu...
Cerrada does 8 months | next call scheduled for the month of